Volume 27, Issue 157 (2-2018)
J Mazandaran Univ Med Sci 2018, 27(157): 230-235 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Saleh Tabari Y, Bakhshi O, Mohammadpour A, Hoseini V, Haghi Aminjan H, Shokrzadeh M. Evaluation of NQO1 Polymorphism in Gastric Adenocarcinoma. J Mazandaran Univ Med Sci 2018; 27 (157) :230-235
URL: http://jmums.mazums.ac.ir/article-1-8490-en.html
URL: http://jmums.mazums.ac.ir/article-1-8490-en.html
Yahya Saleh Tabari 
, Ommolbanin Bakhshi , Abbas Mohammadpour , Vahid Hoseini , Hamed Haghi Aminjan , Mohammad Shokrzadeh
, Ommolbanin Bakhshi , Abbas Mohammadpour , Vahid Hoseini , Hamed Haghi Aminjan , Mohammad Shokrzadeh
Abstract: (5178 Views)
Background and purpose: Gastric cancer is the second most common cause of cancer worldwide and despite huge advances in treatments, the chance of survival is very low even in surgery cases. Having a genetic predisposition plays an important role in cancer development. Polymorphisms in the NQO1(NAD(P)H Quinone dehydrogenase 1) gene could affect the activity of the gene and also the susceptibility to gastric cancer. The aim of this study was to evaluate the effect of the polymorphism of NQO1 gene on gastric cancer.
Materials and methods: This case-control study was performed in 100 patients with gastric cancer and 100 healthy individuals as benchmarks. Genomic DNA was extracted from peripheral blood leukocytes. Then, genotyping for detecting NQO1 -609 C>T promoter gene polymorphism was carried out using PCR-RFLP. Data analysis was performed in MedCalc V9.
Results: NQO1 rs1800566 allelic and genotypic frequencies were not significantly different between the patients and controls (P= 0.14، χ2= 2.16(
Conclusion: Screening of -609C>T NQO1 polymorphism was not found as a useful marker in detecting personal sensitivity to gastric cancer, therefore, would not be helpful in gastric cancer prevention and treatment processes.
Materials and methods: This case-control study was performed in 100 patients with gastric cancer and 100 healthy individuals as benchmarks. Genomic DNA was extracted from peripheral blood leukocytes. Then, genotyping for detecting NQO1 -609 C>T promoter gene polymorphism was carried out using PCR-RFLP. Data analysis was performed in MedCalc V9.
Results: NQO1 rs1800566 allelic and genotypic frequencies were not significantly different between the patients and controls (P= 0.14، χ2= 2.16(
Conclusion: Screening of -609C>T NQO1 polymorphism was not found as a useful marker in detecting personal sensitivity to gastric cancer, therefore, would not be helpful in gastric cancer prevention and treatment processes.
Type of Study: Brief Report |
Subject:
Biotechnology
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
